(Q57847675)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21178990%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

Application of the BRAT framework to case studies: observations and insights (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21178990%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21178990%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

B S Levitan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21178990%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

E B Andrews

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21178990%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

A Gilsenan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21178990%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

J Ferguson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21178990%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

R A Noel

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21178990%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

F Mussen

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21178990%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

language of work or name

English

0 references

publication date

22 December 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21178990%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

18 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21178990%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

89

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21178990%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21178990%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

217-224

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21178990%20AND%20SRC:MED&resulttype=core&format=json

Regulatory challenges, reimbursement, and risk-benefit assessment

18 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.280

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.280

Meta-analysis of the efficacy and safety of zolmitriptan in the acute treatment of migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.280

Unbalanced randomization influences placebo response: scientific versus ethical issues around the use of placebo in migraine trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.280

Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.280

A comparative trial of zolmitriptan and sumatriptan for the acute oral treatment of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.280

Comparison of the Efficacy of Zolmitriptan and Sumatriptan: Issues in Migraine Trial Design

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.280

Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan. Eletriptan Steering Committee.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.280

Almotriptan and zolmitriptan in the acute treatment of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.280

Marketed oral triptans in the acute treatment of migraine: a systematic review on efficacy and tolerability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.280

Comparison of rizatriptan 10 mg vs. zolmitriptan 2.5 mg in the acute treatment of migraine. Rizatriptan-Zolmitriptan Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.280

Comparative efficacy of eletriptan and zolmitriptan in the acute treatment of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.280

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.280

A concise display of multiple end points for benefit-risk assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.280

Recent developments in meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.280

Measuring benefit and balancing risk: strategies for the benefit-risk assessment of new medicines in a risk-averse environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.280

inferred from DOI database lookup

7 January 2021

based on heuristic

Zolmitriptan versus sumatriptan for the acute oral treatment of migraine: a randomized, double-blind, international study

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.280

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/CLPT.2010.280

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21178990%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference